MEDICAL-SURGICAL NURSING
MDC III EXAM 1
AND STUDY GUIDE A+
2026/2027
Rasmussen Multidimensional Care III
A+ 5 100%
QUESTIONS VERIFIED EXAM DOMAINS COVERED RATIONALES INCLUDED
CATEGORIES
Breast Disorders & Breast Cancer
Gynecologic Cancers (Cervical, Endometrial, Ovarian)
Male Reproductive Disorders (BPH, Prostate & Testicular
Cancer)
Sexually Transmitted Infections & Related Care
Diagnostics, Nursing Management & Patient Education
STUVIAACTUALEXAM
, SECTION 1: BREAST DISORDERS & BREAST CANCER
Q1.
A 48-year-old woman reports bilateral breast tenderness and multiple mobile lumps that become more prominent before her
menstrual period. The nurse recognizes these findings as most consistent with:
A. Inflammatory breast cancer requiring urgent biopsy
B. Fibrocystic breast changes related to hormonal fluctuation
C. Paget disease of the nipple
D. A fixed malignant mass typical of invasive ductal carcinoma
Correct Answer: B
Rationale:
Fibrocystic changes are common in premenopausal women and produce cyclic pain, tenderness, and mobile lumps that fluctuate with the
menstrual cycle.
Q2.
A postmenopausal client asks when routine screening mammography should begin according to common guidelines referenced
in the course. The nurse correctly responds that average-risk women typically begin annual or biennial mammography at
approximately:
A. Age 25 for all women regardless of risk
B. Age 40–45, with individualized discussion of benefits and risks
C. Only after a first-degree relative is diagnosed
D. Age 70 when symptoms appear
Correct Answer: B
Rationale:
Most major guidelines recommend initiating screening mammography in the early-to-mid 40s for average-risk women, with shared
decision-making about frequency.
Q3.
A client with a newly diagnosed breast mass is scheduled for a core-needle biopsy. The nurse explains that the primary purpose
of this procedure is to:
A. Remove the entire mass in one step
B. Deliver chemotherapy directly into the tumor
C. Obtain tissue for histologic examination to differentiate benign from malignant lesions
D. Measure hormone-receptor status without tissue
Correct Answer: C
Rationale:
Core-needle biopsy provides adequate tissue for pathologic diagnosis, receptor testing, and treatment planning while being less invasive than
open surgical biopsy.
MDC III EXAM 1
AND STUDY GUIDE A+
2026/2027
Rasmussen Multidimensional Care III
A+ 5 100%
QUESTIONS VERIFIED EXAM DOMAINS COVERED RATIONALES INCLUDED
CATEGORIES
Breast Disorders & Breast Cancer
Gynecologic Cancers (Cervical, Endometrial, Ovarian)
Male Reproductive Disorders (BPH, Prostate & Testicular
Cancer)
Sexually Transmitted Infections & Related Care
Diagnostics, Nursing Management & Patient Education
STUVIAACTUALEXAM
, SECTION 1: BREAST DISORDERS & BREAST CANCER
Q1.
A 48-year-old woman reports bilateral breast tenderness and multiple mobile lumps that become more prominent before her
menstrual period. The nurse recognizes these findings as most consistent with:
A. Inflammatory breast cancer requiring urgent biopsy
B. Fibrocystic breast changes related to hormonal fluctuation
C. Paget disease of the nipple
D. A fixed malignant mass typical of invasive ductal carcinoma
Correct Answer: B
Rationale:
Fibrocystic changes are common in premenopausal women and produce cyclic pain, tenderness, and mobile lumps that fluctuate with the
menstrual cycle.
Q2.
A postmenopausal client asks when routine screening mammography should begin according to common guidelines referenced
in the course. The nurse correctly responds that average-risk women typically begin annual or biennial mammography at
approximately:
A. Age 25 for all women regardless of risk
B. Age 40–45, with individualized discussion of benefits and risks
C. Only after a first-degree relative is diagnosed
D. Age 70 when symptoms appear
Correct Answer: B
Rationale:
Most major guidelines recommend initiating screening mammography in the early-to-mid 40s for average-risk women, with shared
decision-making about frequency.
Q3.
A client with a newly diagnosed breast mass is scheduled for a core-needle biopsy. The nurse explains that the primary purpose
of this procedure is to:
A. Remove the entire mass in one step
B. Deliver chemotherapy directly into the tumor
C. Obtain tissue for histologic examination to differentiate benign from malignant lesions
D. Measure hormone-receptor status without tissue
Correct Answer: C
Rationale:
Core-needle biopsy provides adequate tissue for pathologic diagnosis, receptor testing, and treatment planning while being less invasive than
open surgical biopsy.
